Both live attenuated influenza vaccines (LAIV) and inactivated influenza vaccines (IIV)
induce protective immunity against influenza. There is evidence that LAIV induces superior …

The patterns of cellular immune responses induced by live attenuated influenza vaccine
(LAIV) versus those of the trivalent inactivated influenza vaccine (TIV) have not been studied …

BACKGROUND: Immunoglobulin A (IgA) is the predominant antibody produced in response
to mucosal infections. The role of IgA in providing protection against influenza in children …

Please cite this paper as: Ambrose CS et al.(2011) The relative efficacy of trivalent live
attenuated and inactivated influenza vaccines in children and adults. Influenza and Other …

Please cite this paper as: Belshe et al.(2010). Efficacy of live attenuated influenza vaccine in
children 6 months to 17 years of age. Influenza and Other Respiratory Viruses 4 (3), 141 …

Background. The efficacy of live, attenuated live attenuated influenza vaccine (LAIV) and
inactivated influenza vaccine (IIV) is poorly explained by either single or composite immune …

An enzyme-linked immunosorbent assay was used to measure nasal-wash and serum
isotype-specific hemagglutinin antibody responses in 109 seronegative (hemagglutination …

ABSTRACT Since 2003 (US) and 2012 (Europe) the live attenuated influenza vaccine
(LAIV) has been used as an alternative to the traditional inactivated influenza vaccines (IIV) …

Background. Live attenuated influenza vaccines (LAIVs) stimulate a multifaceted immune
response including cellular immunity, which may provide protection against newly emerging …

Cellular immune responses to influenza virus infection and influenza virus vaccination have
not been rigorously characterized. We quantified the effector and memory B-cell responses …